Established in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) focuses on delivering comprehensive multispeciality healthcare. This includes both secondary and tertiary care services, with a network of facilities across India’s Gujarat state.
The organization manages a portfolio of seven multispeciality hospitals and four retail pharmacies. Collectively, these facilities offer a total bed capacity of 490, with an approved capacity of 455 beds and an operational capacity of 340 beds.
Its hospital network comprises:
- Gujarat Kidney and Superspeciality Hospital (Vadodara)
- Gujarat Multispeciality Hospital (Godhra)
- Raj Palmland Hospital Private Limited (Bharuch)
- M/s. Surya Hospital and ICU (Borsad)
- Gujarat Surgical Hospital (Vadodara)
- Ashwini Medical Centre (Anand)
The company additionally runs the Ashwini Medical Store located in Anand.
The Initial Public Offering (IPO) of Gujarat Kidney and Super Speciality Limited, structured as a Book Build Issue, opens for subscription on December 22, 2025, and will close on December 24, 2025. The company seeks to raise approximately ₹250.80 crores, comprising solely a fresh issue of shares, with a price band set between ₹108 and ₹114 per share, each with a face value of ₹2. The allocation is divided with a 10% quota for retail investors, 75% for Qualified Institutional Buyers (QIBs), and 15% for High Net-Worth Individuals (HNIs).
The share allotment is scheduled for December 26, 2025, with a planned listing on both the BSE and NSE on December 30, 2025. Notably, the company has demonstrated significant financial growth, reporting a surge in revenue to ₹40.40 crores in 2025 from ₹5.48 crores in 2024, alongside an increase in profit to ₹9.50 crores from ₹1.71 crores in the same comparative period.
Gujarat Kidney IPO Details
| IPO Date | December 22, 2025 to December 24, 2025 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| IPO Price Band | ₹108 to ₹114 Per Share |
| Lot Size | 128 Shares |
| Total Issue Size | Approx ₹250.80 Crores |
| Issue Type | Book building IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,68,43,250 shares |
| Share Holding Post Issue | 7,88,43,250 shares |
Gujarat Kidney IPO Dates
The subscription window for the Gujarat Kidney IPO commences on December 22 and concludes on December 24. Following the closure, the final basis of allotment is set for December 26, with the company’s shares scheduled to debut on the stock exchanges on December 30.
| IPO Open Date | Mon, Dec 22, 2025 |
| IPO Close Date | Wed, Dec 24, 2025 |
| Tentative Allotment | Fri, Dec 26, 2025 |
| Refunds | Mon, Dec 29, 2025 |
| Credit of Shares to Demat | Mon, Dec 29, 2025 |
| Tentative Listing Date | Tue, Dec 30, 2025 |
| UPI Mandate Confirmation Deadline | 5 PM on Wed, Dec 24, 2025 |
Gujarat Kidney IPO Market Lot
Gujarat Kidney IPO, the minimum market lot is set at 128 shares, requiring an application amount of ₹14,592. Retail investors are permitted to bid for a maximum of 13 lots, which equates to 1,664 shares, representing a total application value of ₹1,89,696.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 128 | ₹14,592 |
| Retail Maximum | 13 | 1,664 | ₹1,89,696 |
| S-HNI Minimum | 14 | 1,792 | ₹2,04,288 |
| S-HNI Maximum | 68 | 8,704 | ₹9,92,256 |
| B-HNI Minimum | 69 | 8,832 | ₹10,06,848 |
